PTGS2 and melanoma: This is consistent with the observation that PGE2 directly suppresses the survival of NK cells (49), which are required to drive remodeling of the TME, including proinflammatory polarization of macrophages and activation of CD8+ T cells, and promote immune control in COX2-deficient melanoma tumors (31).